We empower innovative companies to help defend against major health security threats.

Learn More

NEW DIRECTOR’S CORNER ARTICLE!

Read More

BARDA'S STRATEGIC PLAN

2022 - 2026

Learn More

Healing Lungs is open for abstract submissions.

Apply Now

BARDA announces new partnerships to develop next-gen diagnostics for any respiratory RNA virus.

Learn More

ReDIRECT is open for abstract submissions.

Apply Now

DRIVe funds early stage companies for life saving innovation. Check out our programs below to see current funding opportunities.

programs with multiple funding opportunities

These programs encompass multiple funding opportunities - dig deeper to learn more.

HOST-DIRECTED THERAPEUTICS

icon

Advancing therapies focused on fortifying and restoring balance to the patient's defense mechanisms.

More info

HOST-BASED DIAGNOSTICS

icon

Harness a patient's systemic responses to inform on health threats and clinical impact.

More info

HEALTHCARE INFRASTRUCTURE, IMPLEMENTATION, & IMPACT (HI-3)

icon

Apply the utility of novel health ecosystems, stakeholder collaborations, and real world to data to maximize clinical impact.

More info

Current Open programs

Active programs currently accepting submissions

Healing Lungs

Enact

Advancing technologies that help patients with acute respiratory distress syndrome (ARDS), oxygenate their blood, without further straining ARDS patients' lungs.

Digital Health Tools for Pandemic Preparedness

ReDIRECT

Empowering people to respond to infectious disease outbreaks through rapidly deployable digital health tools.

Bringing Lab Testing to the Home

ReDIRECT

On-demand, at-home detection of biochemical health markers to enable diagnostics and telemedicine services.

Current Active programs

Active programs, but paused for accepting submissions

BEYOND THE NEEDLE

Beyond the Needle

Develop alternative delivery methods for vaccines and other therapeutics.

NGS-based Agnostic Diagnostic

immunechip

A diagnostic test to identify any and every pathogen from a single sample.

IMMUNECHIP+

Eantch

Enhance the usability of 3D human tissue models ("tissue chips") as tools for drug development.

ReDIRECT

ReDIRECT

Repurposing commonly available drugs to rapidly treat conditions caused by exposure to chemical agents.

Closed programs

Past programs, closed and here for reference

COVID-19 RESPONSE

Covid

Rapid and widely available access to COVID-19 testing in the home setting.

ENACT

immunechip

Interpreting physiological signals for pre- or early symptomatic detection of infection.

DRIVe's IMPACT

We change how the government approaches big health security challenges and threats.

We tackle health security threats by seeking breakthrough devices and technologies.

We model our work on the best practices of the entrepreneurial world.

We use tools and authorities to support new technologies, streamline contracting processes, and launch a network of accelerators.

The team is comprised of scientists and venture entrepreneurs dedicated to identifying threats to health security.